318 related articles for article (PubMed ID: 22564368)
21. The development of site-specific drug delivery nanocarriers based on receptor mediation.
Wang X; Li S; Shi Y; Chuan X; Li J; Zhong T; Zhang H; Dai W; He B; Zhang Q
J Control Release; 2014 Nov; 193():139-53. PubMed ID: 24862317
[TBL] [Abstract][Full Text] [Related]
22. Potentials of new nanocarriers for dermal and transdermal drug delivery.
Neubert RH
Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
Witting M; Obst K; Friess W; Hedtrich S
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
[TBL] [Abstract][Full Text] [Related]
24. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
25. [Advances in the investigation of biological effect and surface modification of dendrimers as drug (gene) delivery systems].
He ZH; Kong H; Xu HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):590-5. PubMed ID: 16995320
[TBL] [Abstract][Full Text] [Related]
26. A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers.
Saul JM; Annapragada AV; Bellamkonda RV
J Control Release; 2006 Sep; 114(3):277-87. PubMed ID: 16904220
[TBL] [Abstract][Full Text] [Related]
27. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
Torchilin VP
Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
[TBL] [Abstract][Full Text] [Related]
28. The in vitro biocompatibility of self-assembled hyperbranched copolyphosphate nanocarriers.
Liu J; Huang W; Pang Y; Zhu X; Zhou Y; Yan D
Biomaterials; 2010 Jul; 31(21):5643-51. PubMed ID: 20417961
[TBL] [Abstract][Full Text] [Related]
29. A sight on protein-based nanoparticles as drug/gene delivery systems.
Salatin S; Jelvehgari M; Maleki-Dizaj S; Adibkia K
Ther Deliv; 2015; 6(8):1017-29. PubMed ID: 26305428
[TBL] [Abstract][Full Text] [Related]
30. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
31. A review of stimuli-responsive nanocarriers for drug and gene delivery.
Ganta S; Devalapally H; Shahiwala A; Amiji M
J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822
[TBL] [Abstract][Full Text] [Related]
32. Chitosan-based drug nanocarriers: where do we stand?
Garcia-Fuentes M; Alonso MJ
J Control Release; 2012 Jul; 161(2):496-504. PubMed ID: 22480607
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy.
Hu YL; Fu YH; Tabata Y; Gao JQ
J Control Release; 2010 Oct; 147(2):154-62. PubMed ID: 20493219
[TBL] [Abstract][Full Text] [Related]
34. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
35. A review of in vitro-in vivo investigations on dendrimers: the novel nanoscopic drug carriers.
Gupta U; Agashe HB; Asthana A; Jain NK
Nanomedicine; 2006 Jun; 2(2):66-73. PubMed ID: 17292117
[TBL] [Abstract][Full Text] [Related]
36. Active targeting of brain tumors using nanocarriers.
Béduneau A; Saulnier P; Benoit JP
Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
[TBL] [Abstract][Full Text] [Related]
37. Design and application of multifunctional DNA nanocarriers for therapeutic delivery.
Charoenphol P; Bermudez H
Acta Biomater; 2014 Apr; 10(4):1683-91. PubMed ID: 23896566
[TBL] [Abstract][Full Text] [Related]
38. Functionalization of protein-based nanocages for drug delivery applications.
Schoonen L; van Hest JC
Nanoscale; 2014 Jul; 6(13):7124-41. PubMed ID: 24860847
[TBL] [Abstract][Full Text] [Related]
39. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
Rosenholm JM; Sahlgren C; Lindén M
Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain.
Kasongo KW; Jansch M; Müller RH; Walker RB
J Liposome Res; 2011 Sep; 21(3):245-54. PubMed ID: 21174528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
